Single-arm phase II trial reports strong response with junctional cancer combination
A single-arm phase II trial of 40 patients with locally advanced esophagogastric junction adenocarcinoma reported high pathological response rates, manageable ...
A single-arm phase II trial of 40 patients with locally advanced esophagogastric junction adenocarcinoma reported high pathological response rates, manageable ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.